Novel chemokine receptor inhibition assay

Research output: Patent

Abstract

Ligands MCP-4, MCP-3, RANTES, MCP-2, MCP-1 or eotaxin, has been identified for the G-protein receptor HGBER32.

@misc{d98990e097944ca69468fe670bfbdb70,

title = "Novel chemokine receptor inhibition assay",

abstract = "Ligands MCP-4, MCP-3, RANTES, MCP-2, MCP-1 or eotaxin, has been identified for the G-protein receptor HGBER32.",

keywords = "Chemokine receptor",

author = "Theo Berkhout and Groot, \{P. H. E.\} and Nabil Elshourbagy and Derek Bergsma and White, \{John R.\}",

year = "1998",

language = "English",

type = "Patent",

note = "WO1998009171 A1",

}

TY - PAT

T1 - Novel chemokine receptor inhibition assay

AU - Berkhout, Theo

AU - Groot, P. H. E.

AU - Elshourbagy, Nabil

AU - Bergsma, Derek

AU - White, John R.

PY - 1998

Y1 - 1998

N2 - Ligands MCP-4, MCP-3, RANTES, MCP-2, MCP-1 or eotaxin, has been identified for the G-protein receptor HGBER32.

AB - Ligands MCP-4, MCP-3, RANTES, MCP-2, MCP-1 or eotaxin, has been identified for the G-protein receptor HGBER32.

KW - Chemokine receptor

M3 - Patent

M1 - WO1998009171 A1

ER -